Methylgene Inc.
Methylgene Inc.'s email is info@methylgene.com
and
Methylgene Inc.'s phone number is 514.337.3333
.
MethylGene Inc. (TSX:MYG) is a publicly-traded, clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics with a focus on cancer. The Company's product candidates include: MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases that is in multiple clinical trials for cancer; MGCD290, a fungal Hos2 inhibitor for use in combination with fluconazole for serious fungal infections which has completed Phase I clinical studies; and mocetinostat (MGCD0103), an oral, i...
read more
MethylGene Inc. (TSX:MYG) is a publicly-traded, clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics with a focus on cancer. The Company's product candidates include: MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases that is in multiple clinical trials for cancer; MGCD290, a fungal Hos2 inhibitor for use in combination with fluconazole for serious fungal infections which has completed Phase I clinical studies; and mocetinostat (MGCD0103), an oral, isoform-selective HDAC inhibitor for cancer which has been in multiple Phase II clinical trials and is currently in a Phase II trial in refractory or relapsed follicular lymphoma. Mocetinostat is licensed to Taiho Pharmaceutical Co. Ltd in certain Asian countries. A fourth compound discovered using MethylGene's HDAC platform, EVP-0334 - a potential cognition enhancing agent for neurodegenerative diseases has successfully completed Phase I trials sponsored by EnVivo Pharmaceuticals Inc. MethylGene also has a funded collaboration with Otsuka Pharmaceutical Co. Ltd. for applications in ocular diseases using the Company's proprietary kinase inhibitor chemistry.
show less
Website | methylgene.com | |
Industry | Biotechnology | |
Location | Montréal, Quebec, Canada | |
Employees | 16 | |
Founded | 1997 |
HQ | 7220 Frederick-Banting Quebec | |
Phone | 514.337.3333 | |
info@methylgene.com | ||
Funding | 71,825,730 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | methylgene.com | |
Industry | Biotechnology | |
Location | Montréal, Quebec, Canada | |
Employees | 16 | |
Founded | 1997 | |
linkedin.com/company/methylgene-inc. | ||
HQ | 7220 Frederick-Banting Quebec | |
Phone | 514.337.3333 | |
info@methylgene.com | ||
Funding | 71,825,730 USD |
Top Competitors for Methylgene Inc.
Methylgene Inc. Questions
Where are Methylgene Inc.'s headquarters?
Methylgene Inc.'s headquarters are in 7220 Frederick-Banting Quebec
What is Methylgene Inc.'s phone number?
Methylgene Inc.'s phone number is 514.337.3333
What is Methylgene Inc.'s official website?
Methylgene Inc.'s website is methylgene.com
How many employees are working in Methylgene Inc. right now?
Methylgene Inc. has
16 employees.
View the Email and Phone Numbers for all 16 working at Methylgene Inc..
What is Methylgene Inc.'s industry?
Methylgene Inc.'s industry is
Biotechnology
Who are Methylgene Inc.'s top competitors?
Methylgene Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Methylgene Inc.'s email address?
Methylgene Inc.'s email address is info@methylgene.com
What are Methylgene Inc.'s categories?
Methylgene Inc.'s categories are Biopharma, Biotechnology, Clinical Trials
What is Methylgene Inc.'s location?
Methylgene Inc.'s location is
Montréal, Quebec, Canada
When was Methylgene Inc.'s founded?
Methylgene Inc.'s founding year is 1997
What is Methylgene Inc.'s funding?
Methylgene Inc.'s funding is 71,825,730 USD
What is Methylgene Inc.'s current status?
Methylgene Inc.'s current status is closed
Top Methylgene Inc. Employees
Director Clinical Operations
drpetite1@yahoo.com
+1858-332-3410
Executive Assistant
+1609-306-5077
Senior Scientist I
clemoyne@videotron.ca
Human Resources Manager
barrettc@methylgene.com
Clinical Project Manager
mtawashi@neurochem.com
Research Assistant
serge_gravel@hotmail.com
Director Clinical Operations
drpetite1@yahoo.com
+1858-332-3410